PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2024Lara D. Veeken16 citationsOpen Access

Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

View Full Paper
IAIrene Altabás‐GonzálezUniversity Hospital Complex Of VigoJPJosé María Pego‐ReigosaUniversity Hospital Complex Of VigoCMCoral MouriñoUniversity Hospital Complex Of Vigo

Key Points

Key points are not available for this paper at this time.

Abstract

To provide an overview on the current use of belimumab (BLM) in SLE patients in clinical practice and to examine its efficacy in terms of standardized outcomes, drug survival, as well as patient and safety profiles.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Altabás‐González et al. (2024) studied this question.

synapsesocial.com/papers/68e740ffb6db6435876ba0d2https://doi.org/10.1093/rheumatology/kead696
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P153 Real world experience with Belimumab in systemic lupus erythematosus patients in a Portuguese single center cohort2024
  2. 2P158 Belimumab for the treatment of systemic lupus erythematosus in the real world: a single center study2024 · 1 citations
  3. 3Belimumab 10 years later: how drug positioning has changed2024
  4. 4Efficacy of belimumab in children with systemic lupus erythematosus2026
  5. 5Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus2026